Muscle-strengthening work is associated with lower all-cause, cardiovascular, and cancer mortality risk. This claim cites three references. A 2022 meta-analysis of 16 prospective cohort studies in the British Journal of Sports Medicine found muscle-strengthening activities associated with a 10–17% lower risk of all-cause mortality, cardiovascular disease, total cancer, and diabetes, following a J-shaped dose-response in which the association was strongest at 30–60 minutes of strength training per week and weakened beyond that. A 2022 review of how much resistance exercise benefits healthy aging and longevity reported a 21% lower all-cause mortality for resistance exercise alone and 40% when it was combined with aerobic exercise. A 2024 cohort study of weight training in older adults found any amount associated with lower all-cause, cardiovascular disease, and cancer mortality.
These are observed associations from cohort studies tracking hundreds of thousands of people, not randomized intervention effects. The 30–60 minute figure is the shape of that association in the 2022 meta-analysis rather than a training prescription: no reference cited here establishes a weekly session count, a progression scheme, a modality choice, or a recovery protocol.
Regular muscle-strengthening work is associated with lower type 2 diabetes risk. The claim’s single reference is the same 2022 British Journal of Sports Medicine meta-analysis, which found a 17% lower diabetes risk with regular muscle-strengthening activity. That too is an observed association in cohort data rather than a demonstrated prevention effect.